N-Acetylglutamate Synthase (NAGS) Peptide
Quick Overview for N-Acetylglutamate Synthase (NAGS) Peptide (ABIN936130)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- YLDKFVVSSS RQGQGSGQML WECLRRDLQT LFWRSRVTNP INPWYFKHSD
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NAGS antibody,
Alternative Names: NAGS control peptide, NAGS antibody Blocking Peptide, Anti-NAGS Blocking Peptide, N-Acetylglutamate Synthase Blocking Peptide, AGAS Blocking Peptide, ARGA Blocking Peptide, MGC133025 Blocking Peptide -
Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- NAGS (N-Acetylglutamate Synthase (NAGS))
-
Background
- NAGS is a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia.
-
Molecular Weight
- 58 kDa
Target
-